stella
beta
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer — Stella
Recruiting
Back to Small Cell Neuroendocrine Carcinoma of Bladder trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
United States
Johns Hopkins University: Sibley Memorial Hospital, Washington D.C., District of Columbia
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
View full record on ClinicalTrials.gov